(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...
Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronization, according to a Late-Breaking Science presentation at EHRA 2026, the annual congress of ...
Abbott (ABT)'s investigational AVEIRâ„¢ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural ...
Abbott (NYSE:ABT) today shared new study findings supporting its pulsed field ablation (PFA) and conduction system pacing ...
Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pacemaker leads. The expanded indication ...
Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction system pacing (CSP) ...
SAN DIEGO--(BUSINESS WIRE)--#HRX2024--Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the publication of a groundbreaking case in Heart Rhythm Case ...
New left bundle branch block (LBBB) following TAVI has grown less common over the past decade, but the conduction disturbance remains a substantial complication associated with worse morbidity, ...
Yogesh N. Reddy, MBBS: Hi. This is Yogesh Reddy, cardiology fellow at Mayo Clinic. Today we will be discussing the very common clinical scenario of a left bundle branch block (LBBB) on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results